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Summary
X-linked hypohidrotic ectodermal dysplasia (XLHED),
the most common of the ectodermal dysplasias, results
in the abnormal development of teeth, hair, and eccrine
sweat glands. The gene responsible for this disorder,
EDA1, was identified by isolation of a single cDNA that
was predicted to encode a 135–amino-acid protein. Mu-
tations in this splice form were detected in !10% of
families with XLHED. The subsequent cloning of the
murine homologue of the EDA1 gene (Tabby [Ta]) al-
lowed us to identify a second putative isoform of the
EDA1 protein (isoform II) in humans. This EDA1 cDNA
is predicted to encode a 391-residue protein, of which
256 amino acids are encoded by the new exons. The
putative protein is 94% identical to the Ta protein and
includes a collagen-like domain with 19 repeats of a Gly-
X-Y motif in the presumptive extracellular domain. The
genomic structure of the EDA1 gene was established,
and the complete sequence of the seven new exons was
determined in 18 XLHED-affected males. Putative mu-
tations, including 12 missense, one nonsense, and four
deletion mutations, were identified in ∼95% of the fam-
ilies. The results suggest that EDA1 isoform II plays a
critical role in tooth, hair, and sweat gland morphogen-
esis, whereas the biological significance of isoform I re-
mains unclear. Identification of mutations in nearly all
of the XLHED families studied suggests that direct mo-
lecular diagnosis of the disorder is feasible. Direct di-
agnosis will allow carrier detection in families with a
single affected male and will assist in distinguishing
XLHED from the rarer, clinically indistinguishable, au-
tosomal recessive form of the disorder.
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Introduction
X-linked hypohidrotic ectodermal dysplasia (XLHED;
MIM 305100), the most common form of the ecto-
dermal dysplasias, results in the abnormal development
of teeth, hair, and eccrine sweat glands (Clarke 1987;
Zonana 1993). It has been suggested that the associated
morphological defects result from a failure of cell sig-
naling or cell migration during the epithelial-mesenchy-
mal inductive process (Holbrook 1988). Identification
of the EDA1 gene is of importance in the understanding
of the molecular basis of XLHED, as well as the mo-
lecular mechanisms involved in normal tooth, hair, and
eccrine–sweat gland development. It also should permit
direct mutation testing for XLHED in potentially af-
fected males and carrier females.
Heterozygous carriers of XLHED may have minor or
moderate degrees of hypodontia, hypotrichosis, and hy-
pohidrosis, although many show no obvious clinical
manifestations (Pinheiro and Freire-Maia 1979). Be-
cause of this clinical variation, presumably caused by
random X inactivation (Lyonization), accurate diagnosis
of carrier females is difficult. Although indirect testing
for carrier status by linkage analysis is possible in in-
formative families (Zonana 1993), carrier detection by
this method is impossible in families with single affected
individuals, male or female, whose disorder may be the
result of a de novo mutation. Detection of mutations
within the EDA1 gene is also of importance for families
with only a single affected sibship, since a rarer, auto-
somal recessive form of the disorder is clinically indis-
tinguishable from XLHED, in affected males (Munoz et
al. 1997).
The EDA1 gene recently was isolated by positional
cloning (Kere et al. 1996). A single 858-bp cDNA, rep-
resenting a full-length transcript composed of two exons,
was identified from an adult–sweat gland cDNA library.
In situ analysis showed that the EDA1 gene is expressed
in hair follicles and in the epidermis of adult skin. The
putative gene product is a 135–amino-acid protein (iso-
form I) that has no clear homology to other proteins.
The protein is predicted to contain a single transmem-
brane domain, and fractionation studies of transfected
cell lines showed that the protein product is localized to
Monreal et al.: New EDA1 Splice Form and XLHED Mutations 381
the plasma membrane (Ezer et al. 1997). Three lines of
evidence suggested that there are unidentified alternative
transcripts of the EDA1 gene. First, although the full
length of the EDA1 cDNA was 858 bp, a predominant
5–6 kb transcript was detected, by northern analysis, in
several human tissues (Kere et al. 1996). Second, mu-
tation screening of 173 unrelated families with XLHED
showed that only 7% of the families were likely to have
mutations within exon 1, and none had variants within
exon 2 (Ferguson et al. 1998). Finally, cDNAs from the
homologous murine gene, Tabby (Ta), recently were iso-
lated by our group and by others and were found to
include alternative exons (Ferguson et al. 1997; Srivas-
tava et al. 1997). The Ta cDNA was 87% identical to
exon 1 of EDA1 but was followed by an alternative
sequence, lengthening the predicted open reading frame
(ORF) by 768 bp. As seen with the EDA1 cDNA, the
Ta cDNA was found, by northern analysis, to hybridize
to a 5–6 kb transcript. The anticipated Ta protein is 391
amino acids and, as with the EDA1 protein, contains a
likely single transmembrane domain. In addition, the
predicted Ta protein includes a short collagen-like do-
main, (Gly-X-Y)19.
In this article, we report the isolation of an EDA1
cDNA splice form that is homologous to the Ta cDNA
and that codes for a putative, second isoform of the
EDA1 protein (isoform II). Nearly all of the mutations
associated with XLHED are located within the exons
identified in this new splice form. These results provide
evidence that EDA1 isoform II is essential for hair, tooth,
and eccrine–sweat gland morphogenesis. In addition, the
identification of the additional exons permits direct mo-




Affected males from 18 unrelated families with pre-
sumed XLHED were selected for mutation analysis of
the EDA1 gene. Genomic DNA had been extracted pre-
viously and had been analyzed for mutations within ex-
ons 1 and 2 of the EDA1 gene, but no mutations had
been found (Ferguson et al. 1998). All affected males
had the classic XLHED phenotype, including tooth, hair,
and sweat gland abnormalities. Ten of the families
showed vertical transmission of the trait, with two or
more affected generations. Eight families had a single
affected generation, with two affected brothers in three
of the families and a single affected male in five of the
families. None of the families was consanguineous or
had severely affected females. When applicable, DNA
samples from other family members were studied to de-
termine if the variants detected represented de novo mu-
tations. Appropriate informed consent was obtained
from all subjects included in this study, in accordance
with the institutional review board guidelines of Oregon
Health Sciences University.
Isolation and Analysis of EDA1 cDNAs
A human cDNA library constructed by means of
mRNA isolated from 20–22-wk fetal liver tissue was
obtained from Clontech. The DNA primers used for
PCR amplifications are listed in table 1. PCR reactions
for the cDNA amplifications included 16.6 mM
(NH4)SO4, 67 mM Tris (pH 8.8), 6.7 mM MgCl2, 170
mg BSA/ml, 6.7 mM EDTA, 10 mM b-mercaptoethanol,
10 ng cDNA, 12.5 pmol of each primer, 25 nM dNTP,
and 0.75 U AmpliTaq polymerase (Perkin-Elmer). Re-
actions were cycled at 92C for 30 s, 58C for 30 s, and
72C for 1 min, for 32 cycles. PCR products were elec-
trophoresed on agarose gels, purified by use of
GeneClean (Bio101), and sequenced by use of Taq
DyeDeoxy Terminators (Applied Biosystems). Sequenc-
ing reactions were run on aModel 373ADNA sequencer
(Applied Biosystems). Alignments of nucleotide and pro-
tein sequences were performed by use of the FASTA pro-
gram (Pearson 1994). Nucleic acid sequence-similarity
searches, which were compared against the nonredun-
dant sequence and expressed-sequence-tag databases of
the National Center for Biotechnology Information,
were performed by use of the BLAST program (Altschul
et al. 1990).
Analysis of EDA1 Gene Structure
With the exception of exons 1–3, PCR amplification
between all exons was achieved by use of 1 U of rTth
DNA polymerase XL (Perkin-Elmer) in a reaction mix-
ture with 1# Buffer 2, 1 mMMg(OAc)2, 800 mMdNTP,
30 pmol of each primer, and 10 ng of human YAC DNA
template yWXD1341. Intron sizes were estimated by
agarose-gel electrophoresis of the PCR products. DNA
primer sequences are listed in table 1. The reactions were
heated to 94C for 1 min and to 60C for 5 min, for a
total of 30 cycles, followed by incubation at 72C for
10 min. Vectorette PCR was used to obtain the intron
sequence flanking exon 3 (Arnold and Hodgson 1991).
PCR products containing the intron/exon boundaries
were sequenced as described in the preceding section.
Exons 2, 3, and 9 were physically mapped by use
of human YACs yWXD1851, yWXD3583, and
yWXD1341, which were obtained from the American
Type Culture Collection. Amplification of the exons
from these YACs was performed by use of the Taq PCR
conditions described in the preceding section.
Table 1
DNA Primers Used in This Study
Amplification
Type and
Exon(s) Forward Primer (5′r3′) Reverse Primer (5′r3′) Sequencing Primer(s) (5′r3′)a Methodb
cDNA:
1–3 ACCTCTGGCACCCTAAGCAGC GCCATCTGCTCCTTCAT ) )
1–5 Same as for exons 1–3 CCAGGGGGTCCTTGAGG ) )
1–7 Same as for exons 1–3 TTGAATTGCTGACCCTTGGC ) )
1–9 Same as for exons 1–3 CTGGGAAGTCACATAGGCC ) )
Interexon, for
genomic structure:
3–4c TTGTAATTTTTACAGATGGCCC ACAGACAGACAATGCTGAAAG ) )
4–5 GCCCAGTTAAAAACAAGAAAAAG GGTCCTGGAGGGCCATTG ) )
5–6 GACCACCTGGTCCTCCA TGGTTTTCTCGAGTTCCAGC ) )
6–7 GCTGGAACTCGAGAAAACCA TTGAATTGCTGACCCTTGGC ) )
7–8 GCCAAGGGTCAGCAATTCAA CACCTTGGGGTTCATAGTGA ) )
8–9 TCACTATGAACCCCAAGGTG GGCAAAGTCAGTGAAGTTGATG ) )
Exon, for
mutation screening:
1d GTCGGCCGGGACCTCCTC GCCGCCGCCCCTACTAGG F: GGTGACTGGTGATGGGGCTGTC S
R: AGTTGCGCTCGGAGTTG
2e TGGCTTCTCTAGTTAGGTTGGG CATCTCAAATTTTCCTTCTGGG F: TGGCTTCTCTAGTTAGGTTGGG S
R: CATCTCAAATTTTCCTTCTGGG
3 GGGCTCAGGGTTTAGACACA CTCTATAAGGGCCTCATCTC F: TTGTAATTTTTACAGATGGCCC S
R: GCTCACGCCTGTAATCCTA
4 GTGGCCTCAGGAGTCAGAAG GAAAGAGGTGAATCATCACTGAA R: ACAGACAGACAATGCTGAAAG S
5f CGGGAGGTGGAGGTTTCA CACCTTAGGGTTCATAGTGA F: GAACTCCAGCCTGGGCAA XL
AGTGAACCGAGATTGTGCCA TGGTTTTCTCGAGTTCCAGC R: CTCTCAGGATCACCCACTC
6g AGAAAGCAGGACCTCCTGG CACCTTAGGGTTCATAGTGA F: GGGGTGCACTCTGACTCTTC XL
GACCACCTGGTCCTCCA CACCTTAGGGTTCATAGTGA R: GAAAACCGTCAGAATCTCCG
7g Same as for exon 6 Same as for exon 6 F: CAGGGGAGAGGGATCAGAAT XL
R: GGGGAGAAGCTCCTCTTTG
8 GCCAAGGGTCAGCAATTCAA GCACCGGATCTGCATTCTGG F: GGGTTGTGAACTCCTTGGTA XL
R: GAAGAGTTAGGCCTAAGACC
9 TCACGTGTCCTTTCCTGTTG TTGTCACCCTGGAGTCACT F: TCACGTGTCCTTTCCTGTTG S
R: CACAGCAGCACTTAGAGG
a F  forward; R  reverse.
b S  standard PCR amplification using Taq DNA Polymerase or rTth DNA Polymerase; XL  extra-long amplification.
c The primers are located in the intronic sequence 5′ of exon 3 (forward) and in the intronic sequence 3′ of exon 4 (reverse).
d Primers previously published by Kere et al. (1996).
e Primers previously published by Ferguson et al. (1997).
f Product was obtained by nested PCR amplification.
g Product was obtained by hemi-nested PCR amplification.
Monreal et al.: New EDA1 Splice Form and XLHED Mutations 383
Figure 1 Comparison of the presumptive EDA1 isoform II and Ta proteins. Amino acid identities are indicated by an asterisk (*). The
putative transmembrane domain is boxed. A vertical line designates the start of the protein sequence that is unique to isoform II. The G1y-X-
Y domain is indicated by boldface type, with the 2–amino-acid interruption indicated by shadowed lettering. A blackened circle is shown above
two potential N-linked glycosylation sites, and both C-terminal cysteines are indicated by underlining and boldface type.
Northern Blot Analysis
Human Multi-Tissue northern blots I and IV (Clon-
tech) were hybridized with a 32P-labeled PCR product
that included exons 1–9 (the PCR primers shown in table
1). The filters were hybridized and washed in accordance
with the manufacturer’s recommendations. The signals
were visualized by use of Kodak X-Omat film, with an
exposure time of 3 d.
Mutation Analysis
Exons were amplified from genomic DNA by use of
the primers listed in table 1 and the reaction conditions
with AmpliTaq polymerase, described above. Amplicons
were designed to include x28 bp of the 3′ and 5′ flanking
intronic regions. PCR products were treatedwith Shrimp
Alkaline Phosphatase and Exonuclease I (Amersham),
to remove primers and excess nucleotides, and DNAs
were sequenced by use of the RediVu Thermosequenase
kit (Amersham). Sequencing reactions were visualized
by electrophoretic separation on an 8% polyacrylamide
gel and subsequent exposure on Kodak X-Omat film for
1–3 d. DNA-sequence variants were verified by auto-
mated sequencing using an ABI Model 373A sequencer
(Applied Biosystems). Allele-specific oligonucleotide
(ASO) analysis was performed, to detect polymorphisms
in an unaffected population and to identify de novo mu-
tations in a subset of families, as described in previous
studies (Ferguson et al. 1998). One exception, the
G1136A mutation, was analyzed by restriction digestion
of PCR-amplified exon 8 DNAs, using BanI (New Eng-
land Biolabs). In all cases, genomic DNA samples from
40 control individuals, representing 60 X chromosomes,
were analyzed. The de novo status of Del794–829 in
families ED1050 and ED1204 was established by PCR
amplification of exon 3 sequences, using primers 5′-AGA
AAG CAG GAC CTC CTG G-3′ and 5′-CTC TCA GGA
TCA CCC ACT C-3′, and by separation of the products
on a 3% agarose gel (SeaKem).
Results
Identification of a New EDA1 Splice Form
A novel EDA1 cDNA was PCR amplified from a hu-
man fetal liver library, by use of primers derived from
the sequence of the homologous murine gene, Ta
(GenBank accession number AF004435). The 1.5-kb hu-
man cDNA included 610 bp of sequence that was iden-
tical to the first exon of a previously identified 0.8-
kb EDA1 cDNA (Kere et al. 1996), followed by a
930-bp unique DNA sequence. This cDNA included a
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Table 2





(nt) 5′ Intron/Exon)Exon/Intron 3′ Intron
Intron Size
(kb)
1 637 1–637 ATTCCC)CACCAG/gtgagt 1b 1300
3 106 638–743 ttacag/ATGGCC)CAGATG/gtaagt 2 NDa
4 23 744–766 ttatag/GCCCAG)AAAAAG/ggtaag 3 5.0
5 181 767–947 ttttca/GGAAAG)CTTCTG/gtgagt 4 1.6
6 35 948–982 ttgcag/GTGCTG)AACCAG/gttggc 5 1.0
7 52 983–1034 tgccag/CCAGCT)AGAATG/gtaaga 6 2.8
8 131 1035–1165 actgag/ATCTTT)GTAGAA/gtgagt 7 2.0
9 252 1166–? ttcgag/GTATAC) ) )
a ND  not determined.
1,173-bp ORF, followed by a 160-bp 3′ UTR (Genbank
AF060999). No polyadenylation signal sequence was
identified. The cDNA is predicted to encode a 391-res-
idue protein, of which 256 amino acids are encoded by
new exons. The predicted protein is 94% identical to
the Ta protein and includes a collagen-like domain with
19 repeats of a Gly-X-Ymotif, interrupted by two amino
acids between repeats 11 and 12 (fig. 1).
Gene Structure
The exon boundaries and the flanking sequences of
all introns were established by use of either interexon
or vectorette PCR amplification, followed by direct se-
quencing of the intron/exon junctions (table 2; GenBank
AF060992–AF060998). A total of seven new exons in
the EDA1 gene were identified (fig. 2 and table 2). Exons
3–9 are within relatively close proximity to one another,
with introns of 1–5 kb in length. The intron between
exon 1 and exon 3 is estimated to be x300 kb, as was
deduced by analysis of YACs that had been mapped
previously to the EDA1 region (YACs yWXD1850,
yWXD3583, and yWXD1341 map from centromere to
telomere and from 5′ to 3′ of EDA1) (Srivastava et al.
1996). By means of both Southern (Ferguson et al. 1997)
and PCR analysis, exons 3–9 were localized to
yWXD1341 but not to yWXD1850 or yWXD3583
(data not shown). The previously identified exon 2 (Kere
et al. 1996), which is not present in this splice form, is
present on all three YAC clones. When considered to-
gether, these data suggest that the newly identified exons
are 3′ and telomeric to exon 2 and that they map x300
kb from exon 1. Analysis of the murine (Ta) gene struc-
ture revealed that the exon boundaries of the EDA1 and
Ta genes are completely conserved (data not shown).
Expression Studies
Northern blot analysis of RNA isolated from several
human tissues, hybridized with exons 1–9 of the cDNA,
detected a 5–6 kb transcript (fig. 3). No additional hy-
bridization was observed with longer exposures. The
most abundant signal was detected in RNA isolated from
adult heart, pancreas, prostate, and uterus tissues. A
weaker signal was seen in RNA isolated from muscle,
spleen, thymus, testis, and small intestine tissues. To
identify any rare, alternative EDA1 splice products in
the fetal liver library, the cDNAwas amplifiedwithDNA
primers between exon 1 and exon 3, 5, 7, or 9. All PCR
products analyzed had identical sequences, with no dif-
ferences in exon usage. To identify splice products that
contain exon 1 but not the novel exons, the library was
PCR amplified by use of primers from either exon 1 or
exon 3, in the 3′ direction, in combination with library
vector primers. All the PCR products generated with the
exon 1 primer had corresponding products that were
produced with the exon 3 primer, suggesting that all
cDNAs with exon 1 sequences also have exon 3 se-
quences (data not shown). Similarly, all cDNAs with
exon 3 sequences appear to contain exon 1 sequences,
since 5′-directed primers from exon 1 or exon 3, in com-
bination with vector primers, generated corresponding
PCR products.
Finally, since Ta cDNA had been isolated in two
forms, which varied by the presence or absence of nu-
cleotides 958–1000 (Ferguson et al. 1997; Srivastava et
al. 1997), we tested the possibility that the human cDNA
also might have a 42-bp variant. Primers closely flanking
the 42-bp region were used to amplify the human cDNA
library. Only a single 190-bp cDNA product, which in-
cluded the 42-bp variable region, was identified. Anal-
ysis of the intron/exon boundaries shows that these 42
bp are contiguous with exon 8 in genomic DNA; thus,
they do not represent a separate exon but, rather, result
from the use of an alternate splice donor site.
Mutations Identified
Mutation analysis was conducted on genomic DNAs
isolated from 18 families with XLHED. The families
were selected to include some with vertical transmission
of the disease and others with sporadic cases. Every
exon, including flanking splice recognition sequences,
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Figure 2 Gene structure and predicted protein products of EDA1. The anticipated protein products of the two splice forms are depicted
in panels A and C. The vertical lines separate protein regions encoded by different exons. Transmembrane (“TM”) and collagen-like (Gly-X-
Y) domains are shown. The relative positions of the mutations identified in this article are depicted in panel C,with missense mutations indicated
by blackened triangles, deletions indicated by unblackened diamonds, and a nonsense mutation indicated by an asterisk (*). Mutations in exon
1, found in a previous study, are not included in this diagram. The EDA1 gene structure is depicted in panel B, with the numbered boxes
representing exons and the connecting lines representing intronic regions. The start and stop codons are indicated by “ATG” and “TAG.”
was PCR amplified and sequenced. Sequence variants
were confirmed by sequencing the opposing strand of
DNA. DNA changes were confirmed in 17 individuals
(tables 3 and 4). Four individuals were found to have
genomic deletions, two of which also produced frame-
shift mutations. Twelve individuals had a single base-
pair change that was predicted to generate a missense
mutation, and one person had a base-pair substitution
that created a premature termination codon. To deter-
mine whether any of the putative missense mutations
identified are present in an unaffected population and
thus are likely to be a nonpathogenic polymorphism, we
used ASO hybridization to survey 60 X chromosomes.
None of the variants was found to be present in
the control population. Three presumed mutations
(Del794–829, G1136A, and G1285A) each were iden-
tified twice among the 18 affected individuals. For two
of these cases (Del794–829 and G1285A), a de novo
mutation was found in one of the families (ED1204 and
ED1126, respectively), which argues against inheritance
from a common ancestor (fig. 4; for G1285A, data not
shown). Additional sequence variants were identified
within intronic regions. Because these changes did not
appear to affect the splice recognition sites and also were
present in unaffected individuals, they were classified as
nonpathogenic polymorphisms (table 4).
Discussion
Novel EDA1 Splice Form
We have identified a novel EDA1 cDNA containing
a complete ORF that we suggest encodes a novel isoform
of the EDA1 protein (isoform II). Isoform II is highly
homologous to the recently described Ta protein. The
full-length transcript is likely to include a longer 3′ UTR,
since no polyadenylation signal sequence was identified,
and northern analysis indicates that the transcript is 5–6
kb in length. The Ta transcript is also 5–6 kb in length
(Ferguson et al. 1997) and has a 3′ UTR of ∼3.5 kb
(Srivastava et al. 1997).
This novel cDNA is expected to represent the major
EDA1 transcript, since only a single hybridization band
was detected by northern blot analysis. The transcript
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Figure 3 Northern analysis of EDA1 gene expression in human
tissues. An EDA1 probe, including exons 1–9, was hybridized with
polyA-enriched RNA extracted from the tissues indicated above the
figure. The migration of RNA size markers is shown on the left.
Table 3
EDA1 Mutations in XLHED Patients
Family Sequence Change Exon Predicted Effecta
ED1081 C704T 3 R155C
ED1095b C707T 3 R156C
ED1039 G708A 3 R156H
ED1011 C867T 5 P209L
ED1019 G912C 5 G224A
ED1050 Del794–829 5 Del185–196
ED1204b Del794–829 5 Del185–196
ED1018b Del803–830 5 Del188–197, FS
198, Ter 280
ED1097b Del904–938 5 Del221–233, FS
234, Ter 240
ED1197 A986T 7 H252L
ED1007 G1136A 8 G299S
ED1002 G1136A 8 G299S
ED1001 G1202T 9 E321Ter
ED1021 G1285A 9 A349T
ED1126b G1285A 9 A349T
ED1073 C1308A 9 A356D
ED1022 G1311C 9 R357P
a FS  frameshift; Ter  termination.
b De novo mutation.
is expressed in a variety of organs that are not clinically
associated with hypohidrotic ectodermal dysplasia, sug-
gesting that the EDA1 protein may serve a redundant
function in some tissues. No other EDA1 splice products
were identified in this study, including the original 0.8-
kb full-length transcript encoding EDA1 isoform I. The
possibility that other splice forms exist in other tissues
cannot be excluded. In the mouse, only the 5-kb ho-
mologous cDNA and its variants have been identified.
One variant appears to result from the use of a cryptic
splice donor site at the 3′ end of exon 7 (Ferguson et al.
1997), whereas two other variants include portions of
intron 1 or intron 2 and are missing all downstream
exons (Srivastava et al. 1997). The fact that 95% of
XLHED mutations were detected within the newly iden-
tified exons suggests that isoform II is of critical impor-
tance and supports the notion that no additional exons
in the EDA1 gene are likely to be critical for normal
development. The function of EDA1 isoform I, or
whether it actually is translated, remains to be
determined.
Predicted Protein Structure
The predicted EDA1 isoform II protein includes a sin-
gle transmembrane domain and, like EDA1 isoform I,
is likely to be a cell-surface protein with a type II ori-
entation (the C-terminus projecting extracellularly) (Ezer
et al. 1997). The predicted collagen domain (Gly-X-Y)19
may form a triple helix with either itself or the collagen
domains of other proteins, resulting in the formation of
either homotrimeric or heterotrimeric complexes. The
three cysteine residues that present in the C-terminal
domains of both the mouse and the human proteins may
serve to stabilize such trimeric complexes. Although the
protein sequence itself does not suggest a function, we
expect that the EDA1 protein may play a role in inter-
cellular signaling, as either a membrane-bound ligand
or a cell-surface receptor or coreceptor, or that it may
serve a function in cell adhesion or cell migration,
through interactions with the extracellularmatrix.Other
membrane-associated proteins with collagen domains
include collagen XIII and XVII, a macrophage scavenger
receptor, and a bacteria-binding macrophage receptor
(Rohrer et al. 1990; Acton et al. 1993; Gatalica et al.
1997; Peltonen et al. 1997).
An overall high degree of sequence conservation (94%
identity) was found between the predicted EDA1 iso-
form II and Ta proteins. This conservation is particularly
striking in the C-terminal 211 amino acids, which begin
with the Gly-X-Y domain and in which only a single,
conservative substitution at position 241 is present. The
extreme conservation in the C-terminus suggests that it
is of critical importance to protein function and that it
may interact with other proteins that also are highly
conserved.
Functional Implications of Identified Mutations
This study identified mutations within exons 3–9 of
EDA1 in 94.4% (17/18) of the families studied. When
considered with the previous mutation analysis of exon
1, which found mutations in ∼7%–8% of XLHED fam-
ilies (Ferguson et al. 1998), it was estimated that 95%
of mutations in XLHED patients are located within the
1,173-bp coding region of this splice form. Additional
mutations may be located in the remaining 3′ UTR se-
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Table 4
Polymorphisms Detected in the EDA1 Gene
Intron Position (5′)3′) Variant
3 28 T or A
4 11, 12 CT or Del
5 11 C or T
Figure 4 Agarose-gel analysis of Del794–829. Exon 5 was PCR
amplified from samples from ED1050 and ED1204 family members
and then was separated on a 3% agarose gel and stained with ethidium
bromide. Circles represent females, with a dot indicating XLHED car-
rier status. Blackened boxes represent affected males. Molecular size
markers are shown in lane 1, and control DNAs from unrelated, un-
affected males are shown in lanes 2 and 8.
quence, in regulatory elements, or in unsequenced in-
tronic regions or may include large genomic rearrange-
ments that would have been undetectable by the
techniques used in this study.
Although the identified putative mutations are het-
erogeneous, more than half the individuals (11/18) were
found to have changes within the coding regions of ex-
ons 5 and 9. These two exons account for ∼40% of the
ORF. Six mutations were detected in exon 5, including
four deletions 28–36 bp in length. Exon 5 encodes the
Gly-X-Y domain, and deletions within it may be en-
riched because of the high frequency of repeated se-
quences. Indeed, one deletion (Del794–829) identified
in two unrelated families is flanked by a 17-bp repeated
sequence containing only two nucleotide differences.
This deletion is predicted to truncate the collagen do-
main of the protein but otherwise leaves the protein
intact. If the resulting mutant protein is stable, the im-
plication is that the collagen domain is required for nor-
mal protein function. Two missense mutations may also
disrupt the collagen domain. In one case, the glycine of
a Gly-X-Y triplet is substituted by an alanine. In another
variant, a third-position proline (Gly-X-Pro) is substi-
tuted by a leucine. The third-position proline plays an
important role in stabilizing the collagen helix (Brodsky
and Shah 1995). The coding region of exon 9 also con-
tains a disproportionate share of mutations (all mis-
sense). Three changes cluster within an 8–amino-acid
region, highlighting the importance of this domain for
either protein stability or function. Also of note, this
region overlaps with the C-terminal cysteine domain,
which may stablilize intermolecular associations.
Finally, a mutation identified twice in exon 8,
G1136A, is located within the 42-bp region previously
found to be deleted in one of the Ta splice forms (Fer-
guson et al. 1997). This suggests that the 14–amino-acid
region encoded by the sequence is important in at least
some, if not all, tissues.
Diagnostic Applications
Linkage-based molecular diagnostic testing for
XLHED has been available for ∼10 years and can sig-
nificantly improve carrier-risk estimates (Zonana et al.
1988, 1989, 1992). However, linkage analysis is limited
to families with two or more affected individuals, and
multiple family members must be available and coop-
erative. The results of this work, combined with those
of our previous study of exons 1 and 2, indicate that
∼95% of mutations can be detected in individuals with
presumed XLHED and that direct mutation screening is
now a practical option.
The finding that approximately half of all identifiable
mutations are within exon 5 and the coding region of
exon 9 suggests that initial analysis of these two exons
would provide the most efficient approach in a muta-
tion-detection protocol. Since these two coding regions
are relatively small (181 bp and 252 bp, respectively),
they would be appropriate for direct sequencing, screen-
ing by SSCP (Sheffield et al. 1993), dideoxy fingerprint-
ing (Liu et al. 1996), or other mutation-detection meth-
ods (Grompe 1993). Amplification of exon 5 may reveal
deletions large enough to be detectable by agarose-gel
analysis, as was seen in four families in this study (fig.
4). If no mutations are present in exons 5 and 9, screen-
ing or sequencing of exons 1, 3, 7, and 8 should be
performed and may detect an additional 40% of mu-
tations. No mutations were detected in exons 4 and 6;
however, they represent only ∼5% of the coding se-
quence, and analysis of a larger set of patients may reveal
mutations in these exons as well. In families in which
mutations are not detected, linkage analysis still can be
used when the family is informative.
Five families had a negative family history and an
unaffected mother and, thus, potentially were infor-
mative as to whether the mutation was de novo. In all
five families, the mutations (three deletions and twomis-
sense) were found to be de novo, thus indicating that
they arose either during oogenesis or postzygotically.
With regard to the latter possibility, there was no sign
of mosaicism when sequence analysis was performed.
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This is in contrast with the results of a previous study
(Zonana et al. 1994) that indirectly assessed new mu-
tations by use of marker haplotypes, which indicated
that 7 of 9 de novo mutations occurred either during
spermatogenesis or postzygotically. Although the num-
bers are small, if the results of the two studies are com-
bined, there appear to be equal rates of mutation during
oogenesis and spermatogenesis. The direct identification
of de novo mutations significantly decreases the carrier
risk of female relatives, barring gonadal mosaicism.
Putative mutations were detected in 9 of 10 families
with two or more affected generations. The one family
in which a mutation was not detected is the largest we
have studied, with a history of seven-generation involve-
ment, classic clinical findings of XLHED, and a multi-
point LOD score of 2.70 for linkage to the EDA1 locus
(Zonana et al. 1992). Presumptive mutations were de-
tected in all eight families with a single affected gener-
ation, a pedigree type that also would be compatible
with the rarer, autosomal recessive form of the disorder.
This finding supports previous observations that the au-
tosomal recessive form of the disorder is infrequent,
compared with the X-linked form. Review of clinical
features showed no obvious phenotype/genotype cor-
relation between individuals with missense mutations
and those with either deletions truncating the collagen
domain or frameshift mutations that may yield either an
abnormal truncated protein or no protein at all. This is
similar to our previous analysis of mutationswithin exon
1, which showed no difference in phenotype between
patients with missense mutations and those with exon
deletions or frameshifts (Kere et al. 1996; Ferguson et
al. 1998).
The availability of direct testing for XLHED muta-
tions is a significant advance in diagnostic capabilities.
It will allow carrier detection in families with only a
single affected male and will help differentiate the X-
linked disorder from the rarer, autosomal recessive form
of the disorder. It also should be helpful in distinguishing
sporadic carriers of XLHED from females with an au-
tosomal dominant form of isolated hypodontia (Arte et
al. 1996). Finally, testing also should be useful in the
diagnosis of XLHED in affected male infants, especially
in sporadic cases, before abnormal tooth and hair in-
volvement is apparent. Early diagnosis can avert the sig-
nificant morbidity and mortality due to uncontrolled hy-
perthermia that is associated with the disorder (Clarke
et al. 1987).
Acknowledgments
The authors are grateful to the many clinicians and families
who participated in this study. We also thank R. Wildin and
S. Hayflick for their careful reading of the manuscript. This
work was supported by grant DE11311 from the National
Institute of Dental Research (to J.Z.) and by the National
Foundation for Ectodermal Dysplasias (support to J.Z.).
Electronic-Database Information
Accession numbers and URLs for data in this article are as
follows:
GenBank, http://www.ncbi.nlm.nih.gov/Web/Genbank (for
EDA1 cDNA [AF060999]; EDA1 exons 2–9, including the
flanking intronic sequences [AF060992–AF060998]; and the
murine gene Ta [AF004435])
Online Mendelian Inheritance in Man (OMIM), http://
www.ncbi.nlm.nih.gov/Omim (for XLHED [MIM 305100])
References
Acton S, Resnick D, Freeman M, Ekkel Y, Ashkenas J, Krieger
M (1993) The collagenous domains of macrophage scav-
enger receptors and complement component C1q mediate
their similar, but not identical, binding specificities for poly-
anionic ligands. J Biol Chem 268:3530–3537
Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990)
Basic local alignment search tool. J Mol Biol 215:403–410
Arnold C, Hodgson IJ (1991) Vectorette PCR: a novel ap-
proach to genomic walking. PCR Methods Appl 1:39–42
Arte S, Nieminen P, Pirinen S, Thesleff I, Peltonen L (1996)
Gene defect in hypodontia: exclusion of EGF, EGFR, and
FGF-3 as candidate genes. J Dent Res 75:1346–1352
Brodsky B, Shah NK (1995) Protein motifs. 8. The triple-helix
motif in proteins. FASEB J 9:1537–1546
Clarke A (1987) Hypohidrotic ectodermal dysplasia. J Med
Genet 24:659–663
Clarke A, Phillips DI, Brown R, Harper PS (1987) Clinical
aspects of X-linked hypohidrotic ectodermal dysplasia. Arch
Dis Child 62:989–996
Ezer S, Schlessinger D, Srivastava A, Kere J (1997) Anhidrotic
ectodermal dysplasia (EDA) protein expressed in MCF-7
cells associates with cell membrane and induces rounding.
Hum Mol Genet 6:1581–1587
Ferguson BM, Brockdorff N, Formstone E, Ngyuen T, Kron-
miller JE, Zonana J (1997) Cloning of Tabby, the murine
homolog of the human EDA gene: evidence for a membrane-
associated protein with a short collagenous domain. Hum
Mol Genet 6:1589–1594
Ferguson BM, Thomas NS, Munoz F, Morgan D, Clarke A,
Zonana J (1998) Scarcity of mutations detected in families
with X linked hypohidrotic ectodermal dysplasia: diagnostic
implications. J Med Genet 35:112–115
Gatalica B, Pulkkinen L, Li K, Kuokkanen K, Ryyna¨nen M,
McGrath JA, Uitto J (1997) Cloning of the human type XVII
collagen gene (COL17A1), and detection of novel mutations
in generalized atrophic benign epidermolysis bullosa. Am J
Hum Genet 60:352–365
Grompe M (1993) The rapid detection of unknown mutations
in nucleic acids. Nat Genet 5:111–117
Holbrook KA (1988) Structural abnormalities of the epider-
mally derived appendages in skin from patients with ecto-
dermal dysplasia: insight into developmental errors. Birth
Defects 24:15–44
Monreal et al.: New EDA1 Splice Form and XLHED Mutations 389
Kere J, Srivastava AK, Montonen O, Zonana J, Thomas N,
Ferguson B, Munoz F, et al (1996) X-linked anhidrotic (hy-
pohidrotic) ectodermal dysplasia is caused by mutation in
a novel transmembrane protein. Nat Genet 13:409–416
Liu Q, Feng J, Sommer SS (1996) Bi-directional dideoxy fin-
gerprinting (Bi-ddF): a rapid method for quantitative detec-
tion of mutations in genomic regions of 300–600 bp. Hum
Mol Genet 5:107–114
Munoz F, Lestringant G, Sybert V, Frydman M, Alswaini A,
Frossard PM, Jorgenson R, et al (1997) Definitive evidence
for an autosomal recessive form of hypohidrotic ectodermal
dysplasia clinically indistinguishable from themore common
X-linked disorder. Am J Hum Genet 61:94–100
Pearson WR (1994) Using the FASTA program to search pro-
tein and DNA sequence databases. Methods Mol Biol 24:
307–331
Peltonen S, RehnM, Pihlajaniemi T (1997) Alternative splicing
of mouse alpha1(XIII) collagen RNAs results in at least 17
different transcripts, predicting alpha1(XIII) collagen chains
with length varying between 651 and 710 amino acid res-
idues. DNA Cell Biol 16:227–234
Pinheiro M, Freire-Maia N (1979) Christ-Siemens-Touraine
syndrome: a clinical and genetic analysis of a large Brazilian
kindred. I. Affected females. Am J Med Genet 4:113–122
Rohrer L, Freeman M, Kodama T, Penman M, Krieger M
(1990) Coiled-coil fibrous domains mediate ligand binding
by macrophage scavenger receptor type II. Nature 343:
570–572
Sheffield VC, Beck JS, Kwitek AE, Sandstrom DW, Stone EM
(1993) The sensitivity of single strand conformation poly-
morphism analysis for the detection of single base substi-
tutions. Genomics 16:325–332
Srivastava AK, Montonen O, Saarialho-Kere U, Chen E, Bay-
bayan P, Pispa J, Limon J, et al (1996) Fine mapping of the
EDA gene: a translocation breakpoint is associated with
a CpG island that is transcribed. Am J Hum Genet 58:
126–132
Srivastava AK, Pispa J, Hartung AJ, Du Y, Ezer S, Jenks T,
Shimada T, et al (1997) The Tabby phenotype is caused by
mutation in a mouse homologue of the EDA gene that re-
veals novel mouse and human exons and encodes a protein
(ectodysplasin-A) with collagenous domains. ProcNatl Acad
Sci USA 94:13069–13074
Zonana J (1993) Hypohidrotic (anhidrotic) ectodermal dys-
plasia: molecular genetic research and its clinical applica-
tions. Semin Dermatol 12:241–246
Zonana J, Clarke A, Sarfarazi M, Thomas NST, Roberts K,
Marymee K, Harper PS (1988) X-linked hypohidrotic ec-
todermal dysplasia: localization within the region Xq11-
21.1 by linkage analysis and implications for carrier detec-
tion and prenatal diagnosis. Am J Hum Genet 43:75–85
Zonana J, Jones M, Browne D, Litt M, Kramer P, Becker HW,
Brockdorff N, et al (1992) High-resolution mapping of the
X-linked hypohidrotic ectodermal dysplasia (EDA) locus.
Am J Hum Genet 51:1036–1046
Zonana J, Jones M, Clarke A, Gault J, Muller B, Thomas NS
(1994) Detection of de novo mutations and analysis of their
origin in families with X linked hypohidrotic ectodermal
dysplasia. J Med Genet 31:287–292
Zonana J, Sarfarazi M, Thomas NS, Clarke A, Marymee K,
Harper PS (1989) Improved definition of carrier status in
X-linked hypohidrotic ectodermal dysplasia by use of re-
striction fragment length polymorphism–based linkage anal-
ysis. J Pediatr 114:392–399
